BSX vs JNJ: Which Stock is Better?
Side-by-side comparison of Boston Scientific Corp and Johnson & Johnson in 2026
Comparison Updated:
BSX
Boston Scientific Corp
$95.72
JNJ
Johnson & Johnson
$209.72
Key Metrics Comparison
| Metric | BSX | JNJ | Winner |
|---|---|---|---|
| Market Cap | $144.75B | $492.44B | JNJ |
| P/E Ratio | 52.21 | 19.77 | JNJ |
| EPS (TTM) | $1.87 | $10.34 | JNJ |
| Revenue Growth | 0.2% | 0.1% | BSX |
| Gross Margin | 68.3% | 68.4% | JNJ |
Analyze BSX
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BSX or JNJ a better investment?
Comparing BSX and JNJ: Boston Scientific Corp has a market cap of $144.75B while Johnson & Johnson has $492.44B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BSX and JNJ?
BSX (Boston Scientific Corp) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BSX or JNJ?
Based on P/E ratios, JNJ trades at a lower multiple (19.8x vs 52.2x).